Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
11,571 Blood Cancer
clinical trials

Multiple Myeloma Clinical Trial
Manage Diarrhea in Patients With Multiple Myeloma While Receiving Conditioning Chemotherapy for Autologous SCT
Status: Enrolling, Phase II
Updated: 5/2/2016
The Mayo Clinic
515
mi
from
Rochester, MN
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Study Evaluating KTE-C19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Children's Hospital of Philadelphia
1225
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
Study Evaluating KTE-C19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Sylvester Comprehensive Cancer Center/UMHC
1298
mi
from
Miami, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Penn State Hershey Medical Center
1147
mi
from
Hershey, PA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Oklahoma Medical Center
158
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Oncology Clinical Trial
Matched Targeted Therapy For High-Risk Leukemias and MDS
Status: Enrolling
Updated: 12/31/1969
Seattle Children's Hospital
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
A Study Evaluating KTE-X19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Chicago
609
mi
from
Chicago, IL
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
A Study Evaluating KTE-X19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
572
mi
from
Houston, TX
Click here to add this to my saved trials
Acute Lymphoblastic Leukemia Clinical Trial
A Study Evaluating KTE-X19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of California, Irvine Medical Center
1153
mi
from
Orange, CA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
URMC Related Haplo-identical Donor BMT
Status: Enrolling, Phase I
Updated: 12/31/1969
Wilmot Cancer Institute
1121
mi
from
Rochester, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Cleveland Clinic
898
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of TTI-621 for Patients With Hematologic Malignancies and Selected Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Colorado Blood Cancer Institute
408
mi
from
Denver, CO
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Alabama at Birmingham
676
mi
from
Birmingham, AL
Click here to add this to my saved trials
Leukemia, Myeloid, Acute Clinical Trial
A Study of Venetoclax in Combination With Cobimetinib and Venetoclax in Combination With Idasanutlin in Patients Aged >/= 60 Years With Relapsed or Refractory Acute Myeloid Leukemia Who Are Not Eligible for Cytotoxic Therapy
Status: Enrolling, Phase I, II
Updated: 12/31/1969
USC Norris Cancer Center
1166
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Leukemia, Myeloid, Acute Clinical Trial
A Study of Venetoclax in Combination With Cobimetinib and Venetoclax in Combination With Idasanutlin in Patients Aged >/= 60 Years With Relapsed or Refractory Acute Myeloid Leukemia Who Are Not Eligible for Cytotoxic Therapy
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Stanford Cancer Institute
1329
mi
from
Stanford, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
B-Cell Hematologic Malignancy Vaccination Registry
Status: Enrolling, Phase
Updated: 12/31/1969
Aurora Health Care
633
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Vanderbilt-Ingram Cancer Center
618
mi
from
Nashville, TN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation
Status: Enrolling, Phase I, II
Updated: 12/31/1969
UT Southwestern
349
mi
from
Dallas, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Karmanos Cancer Institute
841
mi
from
Detroit, MI
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma
Status: Enrolling, Phase II
Updated: 12/31/1969
Dana-Farber Cancer Institute
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
To Evaluate the Safety and Pharmacokinetics of Belinostat in Patients Who Have Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes
Status: Enrolling, Phase I
Updated: 12/31/1969
The Oncology Institute of Hope and Innovation
1160
mi
from
Whittier, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Alabama at Birmingham, Comprehensive Cancer Center
683
mi
from
Birmingham, AL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Swedish Cancer Institute
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford Cancer Center Oncology Clinic Pharmacy
405
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Leukemia, Myeloid, Acute Clinical Trial
Dose Escalation Study of JNJ-63709178, a Humanized CD123 x CD3 DuoBody in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase I
Updated: 12/31/1969
Sarah Cannon Research Institute
618
mi
from
Nashville, TN
Click here to add this to my saved trials
Leukemia, Myeloid, Acute Clinical Trial
Dose Escalation Study of JNJ-63709178, a Humanized CD123 x CD3 DuoBody in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase I
Updated: 12/31/1969
Fox Chase Cancer Center
1229
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Clinical Study of CWP232291 in Relapsed or Refractory Myeloma Patients
Status: Enrolling, Phase I
Updated: 3/16/2018
University of Texas M.D. Anderson Cancer Center
572
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
Status: Enrolling, Phase II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
552
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Panobinostat (LBH589): Multiple Myeloma - Autologous Hematopoietic Cell Transplantation (HCT)
Status: Enrolling, Phase II
Updated: 12/31/1969
H. Lee Moffitt Cancer Center & Research Institute
1112
mi
from
Tampa, FL
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Avera Cancer Institute-Aberdeen
534
mi
from
Aberdeen, SD
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Geisinger Medical Center
1151
mi
from
Danville, PA
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Decatur Memorial Hospital
499
mi
from
Decatur, IL
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Iowa Methodist Medical Center
346
mi
from
Des Moines, IA
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Saint Luke's Hospital of Duluth
689
mi
from
Duluth, MN
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Carle Physician Group-Effingham
510
mi
from
Effingham, IL
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Sanford Roger Maris Cancer Center
635
mi
from
Fargo, ND
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Sanford Medical Center-Fargo
632
mi
from
Fargo, ND
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Kaiser Permanente-Fontana
1125
mi
from
Fontana, CA
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Cancer Center of Kansas - Fort Scott
168
mi
from
Fort Scott, KS
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Aurora Cancer Care-Grafton
644
mi
from
Grafton, WI
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Benefis Healthcare- Sletten Cancer Institute
958
mi
from
Great Falls, MT
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Saint Vincent Hospital
691
mi
from
Green Bay, WI
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Aurora BayCare Medical Center
693
mi
from
Green Bay, WI
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Green Bay Oncology Limited at Saint Mary's Hospital
691
mi
from
Green Bay, WI
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Saint Mary's Hospital
689
mi
from
Green Bay, WI
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Saint Francis Cancer Center
885
mi
from
Greenville, SC
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Cleveland Clinic Cancer Center Independence
896
mi
from
Independence, OH
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Kaiser Permanente - Irvine
1154
mi
from
Irvine, CA
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Gundersen Lutheran Medical Center
540
mi
from
La Crosse, WI
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Baptist Memorial Hospital for Women
467
mi
from
Memphis, TN
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Cancer Center of Kansas, PA - Newton
34
mi
from
Newton, KS
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Cancer Center of Kansas, PA - Pratt
51
mi
from
Pratt, KS
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Penn State Health Saint Joseph Medical Center
1184
mi
from
Reading, PA
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Mercy Clinic-Rolla-Cancer and Hematology
330
mi
from
Rolla, MO
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Vince Lombardi Cancer Clinic - Sheboygan
670
mi
from
Sheboygan, WI
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Moffitt Cancer Center
1112
mi
from
Tampa, FL
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
William Beaumont Hospital, Troy
843
mi
from
Troy, MI
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Vince Lombardi Cancer Clinic - Two Rivers
693
mi
from
Two Rivers, WI
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Carle Cancer Center
541
mi
from
Urbana, IL
Click here to add this to my saved trials
Myelodysplastic Syndromes (MDS) Clinical Trial
The National Myelodysplastic Syndromes (MDS) Study
Status: Enrolling
Updated: 1/29/2018
Cleveland Clinic Wooster Family Health and Surgery Center
874
mi
from
Wooster, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Roswell Park Cancer Institute
1057
mi
from
Buffalo, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Chicago
609
mi
from
Chicago, IL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3 Gene Mutation and Who Cannot Receive Standard Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Manhattan Hematology Oncology Associates, p.c
1288
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia
Status: Enrolling, Phase I
Updated: 12/31/1969
OHSU Knight Cancer Institute
1384
mi
from
Portland, OR
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in AML Patient Not Eligible for Transplant
Status: Enrolling, Phase II
Updated: 12/31/1969
Blood and Marrow Transplant Group of Georgia
798
mi
from
Atlanta, GA
Click here to add this to my saved trials
Leukemia, Myeloid, Acute Clinical Trial
A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase II
Updated: 12/31/1969
Mayo Clinic Cancer Center
1068
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
Status: Enrolling, Phase
Updated: 12/31/1969
Greenville Health System Cancer Institute
883
mi
from
Greenville, SC
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
Status: Enrolling, Phase
Updated: 12/31/1969
Fox Chase Cancer Center
1229
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants
Status: Enrolling, Phase
Updated: 12/31/1969
Washington University in St. Louis
413
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL)
Status: Enrolling, Phase I
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
1123
mi
from
Bethesda, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
California Cancer Associates for Research Excellence (cCARE)
1141
mi
from
Encinitas, CA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Vista Oncology, Inc.
1422
mi
from
Olympia, WA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Comprehensive Cancer Center At Desert Regional Medical Center
1081
mi
from
Palm Springs, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
Status: Enrolling, Phase
Updated: 12/31/1969
St. Jude's Medical Center
1154
mi
from
Fullerton, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
Status: Enrolling, Phase
Updated: 12/31/1969
Tulane University Medical Center
697
mi
from
New Orleans, LA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy
Status: Enrolling, Phase
Updated: 12/31/1969
H. Lee Moffitt Cancer Center & Research Institute SC - 5
1112
mi
from
Tampa, FL
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Exploratory Trial to Estimate Proportion of Patients With Tumor Cell Contaminated Leukapheresis Products With and Without Bortezomib With In-vivo Purging - Multiple Myeloma (MM)
Status: Enrolling, Phase II
Updated: 4/30/2018
University of Kansas Medical Center
195
mi
from
Westwood, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Evaluate Safety and Tolerability of XmAb13676 in Patients With CD20-expressing Hematologic Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Mayo Clinic
1062
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Study to Evaluate Safety and Tolerability of XmAb13676 in Patients With CD20-expressing Hematologic Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Michigan
808
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete Remission
Status: Enrolling, Phase III
Updated: 12/31/1969
Site US10010
657
mi
from
Louisville, KY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of ASP2215 (Gilteritinib), Administered as Maintenance Therapy Following Induction/Consolidation Therapy for Subjects With FMS-like Tyrosine Kinase 3 (FLT3/ITD) Acute Myeloid Leukemia (AML) in First Complete Remission
Status: Enrolling, Phase III
Updated: 12/31/1969
Site US10080
1158
mi
from
Whittier, CA
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML
Status: Enrolling, Phase III
Updated: 12/31/1969
Fred Hutchinson Cancer Research Center
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML
Status: Enrolling, Phase III
Updated: 12/31/1969
Banner MD Anderson Cancer Center
841
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML
Status: Enrolling, Phase III
Updated: 12/31/1969
Loyola University Medical Center
600
mi
from
Maywood, IL
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical College of Wisconsin
636
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML
Status: Enrolling, Phase III
Updated: 12/31/1969
Washington University School of Medicine
414
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Study of Iomab-B Prior to HCT vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory AML
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Kansas Cancer Center
194
mi
from
Westwood, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs
Status: Enrolling, Phase III
Updated: 12/31/1969
North Shore Medical Center
613
mi
from
Evanston, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs
Status: Enrolling, Phase III
Updated: 12/31/1969
Bon Secours Saint Francis Hospital
879
mi
from
Greenville, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
572
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Nationwide Children's Hospital
811
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
City of Hope Comprehensive Cancer Center
1152
mi
from
Duarte, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
St. Jude Children's Research Hospital
468
mi
from
Memphis, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospital of Philadelphia
1225
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
New York Medical College
1299
mi
from
Valhalla, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Eastern Maine Medical Center
1575
mi
from
Bangor, ME
Click here to add this to my saved trials
Oncology Clinical Trial
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Floating Hospital for Children at Tufts Medical Center
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Lurie Children's Hospital- Chicago
611
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Chicago Comprehensive Cancer Center
610
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Palmetto Health Richland
972
mi
from
Columbia, SC
Click here to add this to my saved trials
1 … 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 … 116